InflaRx (IFRX) EBIT Margin (2023 - 2025)

InflaRx's (IFRX) quarterly EBIT Margin came in at 48085.53% in Q4 2025, up 1017539887.0% year-on-year from N/an in Q4 2024, and down 407.33% quarter-over-quarter from 9478.14% in Q3 2025.

InflaRx (IFRX) EBIT Margin (2023 - 2025) Analysis & Trends

InflaRx has disclosed EBIT Margin across 3 years of filings, most recently posting 48085.53% for Q4 2025.

  • EBIT Margin for Q4 2025 came in at 48085.53%, up 1017539887.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 1605.05% (up 204832.0% YoY), and the FY2025 annual result was 0.16%, down 13.0% from the prior year.
  • EBIT Margin came in at 48085.53% for Q4 2025 at InflaRx, down from 9478.14% in the prior quarter.
  • In the past five years, EBIT Margin ranged from a high of 9478.14% in Q3 2025 to a low of 10223484.4% in Q4 2024.
  • The 3-year median for EBIT Margin is 36088.3% (2025), against an average of 1246803.57%.
  • Across the five-year window, EBIT Margin slumped 964140937 bps in 2024 and soared 1017539887 bps in 2025, its largest moves.
  • InflaRx's EBIT Margin stood at 582075.02% in 2023, then plunged by 1656 bps to 10223484.4% in 2024, then soared by 100 bps to 48085.53% in 2025.
  • The last three EBIT Margin figures came in at 48085.53% (Q4 2025), 9478.14% (Q3 2025), and 32760.16% (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - -
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn -6.43%
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - -
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -
7 Psyence Biomedical 241.78 Bn 241.78 Bn - -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn 38.10%
9 Abivax 94.26 Bn 94.26 Bn - -
10 InflaRx 764.68 Mn 764.68 Mn 10,877.40 -

Historic Data

Download Data
DateValue
Dec 31, 2025 -48,085.53%
Sep 30, 2025 -9,478.14%
Jun 30, 2025 -32,760.16%
Mar 31, 2025 -36,088.30%
Dec 31, 2024 -10,223,484.40%
Sep 30, 2024 -12,405.24%
Jun 30, 2024 -242,200.14%
Mar 31, 2024 -34,655.19%
Dec 31, 2023 -582,075.02%